Skip to main content
Novartis
language-selector-globe United States | en
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe us
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • About 
      • Novartis in the US 
        • Diversity equity & inclusion  
        • Pay transparency-EPIC 
        • Our code of ethics 
      • Diversity, equity & inclusion  
        • Novartis US EEO / D&I report 2021 
        • Supplier diversity 
      • People and culture 
      • Products 
      • US Country Coordinating Committee 
      • External funding 
      • Contact us 
      Team meeting About
    • Patients and caregivers 
      • Novartis commitment to patients and caregivers 
      • Patient assistance 
      • Diseases 
        • Chronic spontaneous urticaria (CSU) 
        • Hidradenitis suppurativa (HS) 
        • Prostate Cancer (PC) 
        • Paroxysmal Nocturnal Hemoglobinuria (PNH) 
      • Participating in clinical trials 
      • Patient perspectives 
      • Adverse event reporting 
      • The STEP program 
        • Sickle cell disease (SCD) 
        • Program overview 
        • Multiple sclerosis (MS) 
        • Cancer 
        • Application for funding to help address health disparities 
        • Health disparities 
      • Patient resources 
      Patient smiling at doctor image Patients and caregivers
    • Healthcare professionals 
      • Novartis pipeline 
      • Novartis clinical trials 
      • Adverse event reporting 
      • HCP resources 
      • Personalized and Precision Medicine 
      • Health Information Technology Resources 
      Two doctors examining X-ray Healthcare professionals
    • ESG 
      • Ethical behavior 
        • Code of ethics 
        • SpeakUp 
        • PhRMA Code on interactions with healthcare professionals 
        • Business principles 
      • Ethics, risk and compliance 
        • Compliance program 
        • State laws 
        • Corporate integrity agreement 
        • Payments to HCPs & HCOs 
        • Drug Supply Chain Security Act Information 
      • Corporate responsibility 
        • Population health 
        • Novartis in society US reports 
        • Novartis US Foundation 
        • Environmental sustainability 
        • People and communities 
      • Beacon of hope 
        • Beacon of hope: Measurable solutions for health equity 
        • Paving the way for a brighter, more equitable future 
      Novartis East Hanover Campus Landscaping ESG
    • News 
      • News archive 
      • Statements 
      • Stories 
      • Contacts 
      Co-workers having a meeting News
    • Careers 
      • Career search 
      • Meet the teams 
      • Early career 
      • Personal growth 
      • How we work 
      • Employee benefits 
      • Diversity, equity & inclusion 
      • Awards & recognition 
      Meeting in Atrium Careers
    Grandmother, mother and daughter smiling and laughing on a beach Home
  1. Home
  2. Careers
  3. Career Search
  • Sort by Sort ascending
  • Job Title
  • Site
  • Location
  • Division
  • Business
  • Functional Area
  • Date Posted Sort descending
Job Title Site Location Division Business Functional Area Date Posted Sort descending
Time Services Expert – US & Canada INSURGENTES Mexico People & Organization CTS Human Resources Oct 22, 2024
Customer Engagement & Solutions Officer- Oncology Makati City Philippines International Innovative Medicines Marketing Oct 22, 2024
Rheumatology Territory Account Specialist - Fort Wayne - Remote Field Sales (USA) USA US Innovative Medicines Sales Oct 22, 2024
Laboratorijski analitik (m/ž/d) / QC Analyst (m/f/d) Ljubljana Slovenia Operations Innovative Medicines Quality Oct 22, 2024
EA & Program Coordinator Beijing (Beijing) China Corporate Affairs Innovative Medicines Communications & Public Affairs Oct 22, 2024
Hematology Area Manager Moscow (City) Russian Fed. International Innovative Medicines Sales Oct 22, 2024
Senior Product Manager, Digital Finance Barcelona Gran Vía Spain Finance Corporate Audit & Finance Oct 22, 2024
Senior Financial Analyst - FC&C Hyderabad (Office) India Finance CTS Audit & Finance Oct 22, 2024
Study Start-Up Lead Shanghai (Shanghai) China Development Innovative Medicines Research & Development Oct 22, 2024
Government Affairs Manager Moscow (City) Russian Fed. Corporate Affairs Innovative Medicines Communications & Public Affairs Oct 22, 2024
Labortechniker / QC Analyst II (m/w/d), Schaftenau, Tirol, Österreich Schaftenau Austria Operations Innovative Medicines Quality Oct 22, 2024
MR Enshi (Hubei Province) China International Innovative Medicines Sales Oct 22, 2024
Pharmaziepraktikant (w/m/d) im Quality Management ab Mai 2025 Nuremberg (Non-Sales Force) (Novartis Pharma GmbH) Germany Operations Innovative Medicines Others Oct 22, 2024
MR Enshi (Hubei Province) China International Innovative Medicines Sales Oct 22, 2024
Capability Building Manager Milano Italy International Innovative Medicines Sales Oct 22, 2024
MR Enshi (Hubei Province) China International Innovative Medicines Sales Oct 22, 2024
Medical Advisor In Market Brands Vilvoorde Belgium International Innovative Medicines Research & Development Oct 22, 2024
MR Enshi (Hubei Province) China International Innovative Medicines Sales Oct 22, 2024
Customer Engagement Manager - South East Netherlands Amsterdam Netherlands International Innovative Medicines Sales Oct 22, 2024
MR Enshi (Hubei Province) China International Innovative Medicines Sales Oct 22, 2024
R2R Accountant Moscow (City) Russian Fed. Finance CTS Audit & Finance Oct 22, 2024
Medical Science Liaison Novosibirsk Russian Fed. International Innovative Medicines Research & Development Oct 22, 2024
Специалист по системе качества St. Petersburg (City) Russian Fed. Operations Innovative Medicines Quality Oct 22, 2024
MR Enshi (Hubei Province) China International Innovative Medicines Sales Oct 22, 2024
MR Enshi (Hubei Province) China International Innovative Medicines Sales Oct 22, 2024
(高级)医药代表 /(资深)产品专员 Xining (Qinghai Province) China International Innovative Medicines Sales Oct 22, 2024
MR Enshi (Hubei Province) China International Innovative Medicines Sales Oct 22, 2024
Cardiovascular Therapeutic Area Head Warsaw Poland International Innovative Medicines Commercial & General Management Oct 23, 2024
Business Planning Analysis Manager / Analyst INSURGENTES Mexico Biomedical Research CTS Audit & Finance Oct 23, 2024
(高级)医药代表 /(资深)产品专员 Anqing (Anhui Province) China International Innovative Medicines Sales Oct 23, 2024
(高级)医药代表 /(资深)产品专员 Shanghai (Shanghai) China International Innovative Medicines Sales Oct 23, 2024
Liaison en sciences médicales - Cancer du sein Field Non-Sales (Canada) Canada International Innovative Medicines Research & Development Oct 23, 2024
(高级)医药代表 /(资深)产品专员 Anqing (Anhui Province) China International Innovative Medicines Sales Oct 23, 2024
(高级)医药代表 /(资深)产品专员 Shanghai (Shanghai) China International Innovative Medicines Sales Oct 23, 2024
Team Lead, Data Services Hyderabad (Office) India Operations CTS BD&L & Strategic Planning Oct 23, 2024
Quality Assurance Specialist Milano Italy Operations Innovative Medicines Quality Oct 23, 2024
Analitik (m/ž/d) / FRA Analyst (m/f/d) Ljubljana Slovenia Finance CTS Audit & Finance Oct 23, 2024
Data Steward Hyderabad (Office) India Operations CTS Marketing Oct 23, 2024
Customer Engagement Partner Taipei Taiwan International Innovative Medicines Sales Oct 23, 2024
Senior Principal Scientist Hyderabad (Office) India Biomedical Research Pharma Research Research & Development Oct 23, 2024
Manager - FC&C Hyderabad (Office) India Finance CTS Audit & Finance Oct 23, 2024
Tactical Planner Hyderabad (Office) India Development Innovative Medicines Research & Development Oct 23, 2024
Principal Scientist II Hyderabad (Office) India Biomedical Research Pharma Research Research & Development Oct 23, 2024
Analitik (m/ž/d) / FRA Analyst (m/f/d) Ljubljana Slovenia Finance CTS Audit & Finance Oct 23, 2024
Medical Director, Renal London (The Westworks) United Kingdom Development Innovative Medicines Research & Development Oct 23, 2024
Analitik (m/ž/d) / FRA Analyst (m/f/d) Ljubljana Slovenia Finance CTS Audit & Finance Oct 23, 2024
Associated Director – Senior Project Manager Prague Czech Republic Operations CTS Technology Transformation Oct 23, 2024
Medical Science Liaison - Breast Cancer Field Non-Sales (Canada) Canada International Innovative Medicines Research & Development Oct 23, 2024
Sr. Specialist DDIT ISC CSOC Engineering Prague Czech Republic Operations CTS Technology Transformation Oct 23, 2024
GMA Medical Director, RLT London (The Westworks) United Kingdom International Innovative Medicines Research & Development Oct 23, 2024

Pagination

  • ‹ Previous page
  • 1
  • …
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • › Next page

Novartis United States

Navigate Novartis
  • Patients & caregivers
  • Healthcare professionals
  • ESG
  • News
  • Careers
Media center
  • News archive
  • Statements
  • Stories
Our portfolio
  • Novartis clinical pipeline
  • Novartis product portfolio
Other Novartis US websites
  • Oncology HCP resources
  • Medical information
  • Global site
Footer Bottom
© 2024 Novartis Pharmaceuticals Corporation
  • Terms of use
  • Privacy policy
  • Consumer health privacy policy
  • Contacts
  • Site map
  • Web accessibility
Novartis Site Directory
This site is intended for US residents only